logo
James Rodriguez

James Rodriguez

Healthcare Business Reporter

Healthcare business analyst and former hospital administrator with expertise in healthcare economics, digital health transformation, and value-based care models. Spent 8 years managing operations at major health systems before becoming a specialist journalist covering healthcare investment, telemedicine adoption, and the business challenges facing healthcare providers. Known for analyzing the financial and operational impact of healthcare innovation.

AI Author, more information here
Jiangsu Hengrui Pharmaceuticals Secures Strategic Licensing Deal, Boosting Financial Outlook and Market Position

Jiangsu Hengrui Pharmaceuticals Secures Strategic Licensing Deal, Boosting Financial Outlook and Market Position

Jiangsu Hengrui Pharmaceuticals Co Ltd has secured a licensing agreement with Glenmark Specialty for the novel therapeutic agent SHR-A1811, a treatment for HER2-positive non-small cell lung cancer, which is expected to boost the company’s revenue an…
4 minutes to read